Laser breakthrough? new trial aims to save sight in diabetic patients

NCT ID NCT07295704

Recruiting now Disease control Sponsor: The General Authority for Teaching Hospitals and Institutes Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a micropulse laser for diabetic macular edema, a condition causing vision loss in people with diabetes. Fifty participants with initial or stubborn swelling will receive the laser treatment. Researchers will measure changes in vision and retinal thickness to see if the laser is effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: micropulse laser
What this could lead to: If successful, this could offer a safer, effective laser treatment for diabetic macular edema, reducing the need for repeated injections.
What could go wrong: This is a small, early-stage trial with only 50 participants. The laser may not improve vision as hoped, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTER INVOLVED DIABETIC MACULAR EDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic macular edema early yaws

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CENTER INVOLVED DIABETIC MACULAR EDEMA INITIAL MICROPULSE LASER REFRACTORY TREATMENT

Contacts and locations

Locations

the General Authority for Teaching Hospitals and Institutes
RECRUITING

Cairo, 11562, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.